Study design and study population We identified three study cohorts of patients who started SGLT-2 inhibitors versus DPP-4 inhibitors (cohort 1), GLP-1 receptor agonists versus DPP-4 inhibitors (cohort 2), and SGLT-2 inhibitors versus GLP-1 receptor agonists (cohort 3) from April 2013 to the end of available data (December 2019 in Medicare, December 2020 in MarketScan, and April 2022 in CDM)
However, genetics, sun exposure, and lifestyle heavily influence how noticeable or long-lasting your skin-lightening results are
The effect is most noticeable after eccentric exercise like downhill running or heavy resistance training
PAPs require documentation (proof of income, insurance denial letters for Medicaid-eligible patients) and your provider's participation in the application
Observational studies analyze larger populations but cannot isolate every factor affecting mental health
Who is taking the time to investigate these brands